Derma Med Ltd

Derma Med Ltd

Derma Med Ltd (“Derma Medical”) is a UK-based aesthetics training business acquired by PEAL Capital to unlock growth and operational scale.

Through a hands-on value creation strategy, PEAL supported the business with new leadership, brand repositioning, and international expansion planning.

About Derma Medical

Founded in the UK, Derma Medical delivers clinical training in cosmetic injectables for healthcare professionals. The company has expanded its services across the United Kingdom, United States and Australia, offering accredited training, private clinic services, and a pathway to regulated qualifications.

Learn More

PEAL’s Investment Thesis

PEAL saw an opportunity to back a growing brand in the high-demand aesthetics education sector. The business had strong foundations but required strategic support, commercial leadership, and systems to scale. PEAL acquired a controlling interest in 2022.

Value Creation Highlights

✔ Appointed a new sales-focused CEO to lead commercial strategy

✔ Repositioned the brand with a clearer B2B/B2C focus

✔ Introduced board-level operational governance

✔ Expanded international footprint, with training hubs across the UK,  Australia and the U.S.

✔ Enhanced digital infrastructure and marketing performance

Why Now

As reported by McKinsey, the medical aesthetics market remains on track to maintain near double-digit growth through to 2030, necessitating a demand for professionaly trained clinicians.

    1. Many consumers are still spending; they are just looking for more cost-effective products and treatments
    2. Even amid financial constraints, many consumers remain brand loyal
    3. An increasingly diverse consumer base is now more open to medical aesthetics
    4. Manufacturers are innovating to meet growing consumer demand
    5. Channel proliferation offers more options to reach a wider array of consumers
    6. The market remains underpenetrated